Remote Monitored Systems PLC Update on P2F (5456G)
November 26 2020 - 2:00AM
UK Regulatory
TIDMRMS
RNS Number : 5456G
Remote Monitored Systems PLC
26 November 2020
The information contained within this announcement is deemed by
the Company to constitute inside information stipulated under the
Market Abuse Regulation (EU) No. 596/2014. Upon the publication of
this announcement via the Regulatory Information Service, this
inside information is now considered to be in the public
domain.
26 November 2020
Remote Monitored Systems plc ("RMS" or the "Company")
Update on P2F
The Company is providing the following update on its wholly
owned subsidiary Pharm 2 Farm Limited ("P2F").
As noted in the Company's announcement of 11 November 2020, the
Directors have been expecting the delivery and installation of its
new anti-viral mask production line at or around the end of
November. Yesterday, 25 November 2020, the Company received an
update from P2F and the manufacturer of the production line noting
that the production machinery is now expected to undergo final
acceptance testing in mid-December at the manufacturer's premises
in Spain. It will then be shipped, installed and commissioned at
P2F's Biocity premises in Nottingham. Commercial production and
shipment of product is now expected to begin in January 2021.
ENQUIRIES:
Remote Monitored Systems plc
Trevor Brown (Executive Director) +41 7941 55384
Paul Ryan (Non-Executive Chairman) +32 475 754 148
SP Angel Corporate Finance LLP +44 20 3470 0470
Nominated Adviser and joint broker
Stuart Gledhill
Caroline Rowe
Peterhouse Capital Limited +44 20 7469 0930
Joint broker
Lucy Williams
Duncan Vasey
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
UPDFFFEILTLEFII
(END) Dow Jones Newswires
November 26, 2020 02:00 ET (07:00 GMT)
Nanosynth (LSE:NNN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Nanosynth (LSE:NNN)
Historical Stock Chart
From Jul 2023 to Jul 2024